Masterclass Certificate in High-Performance Drug Safety
-- ViewingNowThe Masterclass Certificate in High-Performance Drug Safety course is a comprehensive program designed to equip learners with critical skills in drug safety. This course emphasizes the importance of effective pharmacovigilance, ensuring that learners understand how to monitor, assess, and manage the risks associated with medications.
7,218+
Students enrolled
GBP £ 140
GBP £ 202
Save 44% with our special offer
ě´ ęłźě ě ëí´
100% ě¨ëźě¸
ě´ëěë íěľ
ęłľě ę°ëĽí ě¸ěŚě
LinkedIn íëĄíě ěśę°
ěëŁęšě§ 2ę°ě
죟 2-3ěę°
ě¸ě ë ěě
ë기 ę¸°ę° ěě
ęłźě ě¸ëśěŹí
⢠<strong>Drug Discovery and Development:</strong> An overview of the drug development process, from target identification to market approval. This unit will cover the key steps and challenges in bringing a new drug to market, as well as the regulatory framework governing drug safety.
⢠<strong>Pharmacovigilance:</strong> An introduction to pharmacovigilance, including its history, purpose, and key activities. This unit will cover the principles of signal detection, benefit-risk assessment, and risk management, as well as the role of pharmacovigilance in ensuring drug safety.
⢠<strong>Adverse Event Reporting and Management:</strong> A deep dive into adverse event reporting and management, including the identification, evaluation, and reporting of adverse events to regulatory authorities. This unit will cover the various types of adverse events, the importance of accurate and timely reporting, and the role of healthcare professionals in adverse event management.
⢠<strong>Drug Safety in Clinical Trials:</strong> An exploration of drug safety in clinical trials, including the design and conduct of clinical trials, safety monitoring, and data analysis. This unit will cover the ethical and regulatory considerations in clinical trials, the role of data safety monitoring boards, and the importance of transparency in clinical trial results.
⢠<strong>Risk Management and Minimization:</strong> An examination of risk management and minimization strategies, including the development and implementation of risk management plans (RMPs) and risk minimization measures (RMMs). This unit will cover the various types of RMPs and RMMs, the role of pharmacovigilance in risk management, and the importance of ongoing monitoring and evaluation.
⢠<strong>Pharmacoepidemiology:</strong> An introduction to pharmacoepidemiology, including the design and conduct of observational studies, data analysis, and interpretation. This unit will cover the role of pharmacoepidemiology in drug safety, the
ę˛˝ë Ľ 경ëĄ
ě í ěęą´
- 죟ě ě ëí 기본 ě´í´
- ěě´ ě¸ě´ ëĽěë
- ěť´í¨í° ë° ě¸í°ëˇ ě ꡟ
- 기본 ěť´í¨í° 기ě
- ęłźě ěëŁě ëí íě
ěŹě ęłľě ěę˛Šě´ íěíě§ ěěľëë¤. ě ꡟěąě ěí´ ě¤ęłë ęłźě .
ęłźě ěí
ě´ ęłźě ě ę˛˝ë Ľ ę°ë°ě ěí ě¤ěŠě ě¸ ě§ěęłź 기ě ě ě ęłľíŠëë¤. ꡸ę˛ě:
- ě¸ě ë°ě 기ę´ě ěí´ ě¸ěŚëě§ ěě
- ęśíě´ ěë 기ę´ě ěí´ ęˇě ëě§ ěě
- ęłľě ě겊ě ëł´ěě
ęłźě ě ěąęłľě ěźëĄ ěëŁí늴 ěëŁ ě¸ěŚě뼟 ë°ę˛ ëŠëë¤.
ě ěŹëë¤ě´ ę˛˝ë Ľě ěí´ ě°ëŚŹëĽź ě ííëę°
댏롰 ëĄëŠ ě¤...
ě죟 돝ë ě§ëʏ
ě˝ě¤ ěę°ëŁ
- 죟 3-4ěę°
- 쥰기 ě¸ěŚě ë°°ěĄ
- ę°ë°Ší ëąëĄ - ě¸ě ë ě§ ěě
- 죟 2-3ěę°
- ě 기 ě¸ěŚě ë°°ěĄ
- ę°ë°Ší ëąëĄ - ě¸ě ë ě§ ěě
- ě 체 ě˝ě¤ ě ꡟ
- ëě§í¸ ě¸ěŚě
- ě˝ě¤ ěëŁ
ęłźě ě ëł´ ë°ę¸°
íěŹëĄ ě§ëś
ě´ ęłźě ě ëšěŠě ě§ëśí기 ěí´ íěŹëĽź ěí ě˛ęľŹě뼟 ěě˛íě¸ě.
ě˛ęľŹěëĄ ę˛°ě ę˛˝ë Ľ ě¸ěŚě íë